RELATIONSHIP BETWEEN NASOPHARYNGEAL CARCINOMA AND HIGH ANTIBODY-TITERS TO EPSTEIN-BARR VIRUS-SPECIFIC THYMIDINE KINASE

被引:15
|
作者
DETURENNETESSIER, M
OOKA, T
CALENDER, A
DETHE, G
DAILLIE, J
机构
关键词
D O I
10.1002/ijc.2910430111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [1] NASOPHARYNGEAL CARCINOMA IN AMERICAN-CHILDREN - EPSTEIN-BARR VIRUS-SPECIFIC ANTIBODY-TITERS AND PROGNOSIS
    NAEGELE, RF
    CHAMPION, J
    MURPHY, S
    HENLE, G
    HENLE, W
    INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (02) : 209 - 212
  • [2] EPSTEIN-BARR VIRUS-SPECIFIC ANTIBODY-TITERS IN 7 ALASKAN NATIVES BEFORE AND AFTER DIAGNOSIS OF NASOPHARYNGEAL CARCINOMA
    LANIER, AP
    HENLE, W
    BENDER, TR
    HENLE, G
    TALBOT, ML
    INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (02) : 133 - 137
  • [3] A CLINICAL CORRELATION BETWEEN EPSTEIN-BARR VIRUS-SPECIFIC ANTIBODY-TITERS AND DISEASE-ACTIVITY IN AMERICAN-CHILDREN WITH NASOPHARYNGEAL CARCINOMA (NPC)
    CHAMPION, JE
    NAEGELE, RF
    HENLE, W
    HENLE, G
    MURPHY, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 168 - 168
  • [4] Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
    Coghill, Anna E.
    McGuire, Andrew
    Sinha, Sweta
    Homad, Leah
    Sinha, Irika
    Sholukh, Anton
    Koh, Woon-Puay
    Yuan, Jian Min
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
  • [5] ANTIBODY TO EPSTEIN-BARR VIRUS-SPECIFIC DNASE AS A MARKER FOR THE EARLY DETECTION OF NASOPHARYNGEAL CARCINOMA
    CHEN, JY
    LIU, MY
    CHEN, CJ
    HSU, MM
    TU, SM
    LEE, HH
    KUO, SL
    YANG, CS
    JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (01) : 47 - 49
  • [6] Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
    Straathof, KCM
    Bollard, CM
    Popat, U
    Huls, MH
    Lopez, T
    Morriss, MC
    Gresik, MV
    Gee, AP
    Russell, HV
    Brenner, MK
    Rooney, CM
    Heslop, HE
    BLOOD, 2005, 105 (05) : 1898 - 1904
  • [7] Epstein-Barr Virus-Specific Adoptive Immunotherapy for Recurrent, Metastatic Nasopharyngeal Carcinoma
    Huang, Julian
    Fogg, Mark
    Wirth, Lori J.
    Daley, Heather
    Ritz, Jerome
    Posner, Marshall R.
    Wang, Fred C.
    Lorch, Jochen H.
    CANCER, 2017, 123 (14) : 2642 - 2650
  • [8] EPSTEIN-BARR VIRUS-SPECIFIC SERUM ANTIBODIES - A CHARACTERISTIC FEATURE OF NASOPHARYNGEAL CARCINOMA
    WILMES, E
    WOLF, H
    DEINHARDT, F
    HEAD & NECK SURGERY, 1981, 3 (03): : 258 - 258
  • [9] ANTIBODY TO EPSTEIN-BARR VIRUS-SPECIFIC DNASE AS A MARKER FOR FIELD SURVEY OF PATIENTS WITH NASOPHARYNGEAL CARCINOMA IN TAIWAN
    CHEN, JY
    CHEN, CJ
    LIU, MY
    CHO, SM
    HSU, MM
    LYNN, TC
    SHIEH, T
    TU, SM
    BEASLEY, RP
    HWANG, LY
    LEE, HH
    KUO, SL
    YANG, CS
    JOURNAL OF MEDICAL VIROLOGY, 1989, 27 (04) : 269 - 273
  • [10] EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA - IS THERE AN ETIOLOGIC RELATIONSHIP
    HENDERSON, BE
    LOUIE, EW
    JING, JS
    ALENA, B
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (05) : 1393 - 1395